$MGNX Recent News Seeking Alpha's Biotech Week
Post# of 102855
Posted On: 12/28/2014 12:29:25 PM
$MGNX Recent News
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More 4:00 p.m. Dec. 26, 2014 - Seeking Alpha
3D Systems Climbs Despite Setback 2:00 p.m. Dec. 26, 2014 - TheStreet.com
Macrogenics (MGNX) Highlighted As Today's Perilous Reversal Stock 3:31 p.m. Dec. 23, 2014 - TheStreet.com
MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog 3:00 p.m. Dec. 23, 2014 - Zacks.com
MacroGenics teams up with Janssen in blood cancer 12:08 p.m. Dec. 22, 2014 - Seeking Alpha
MacroGenics Partners With J&J; Stock Jumps 11:33 a.m. Dec. 22, 2014 - Investors Business Daily
Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog 4:50 p.m. Dec. 16, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
MacroGenics (MGNX) Stock: Moving Average Crossover Alert - Tale of the Tape 11:27 a.m. Dec. 15, 2014 - Zacks.com
B7-H3 And PD-1: Are All Checkpoint Inhibitors Created Equal? 8:43 a.m. Dec. 15, 2014 - Seeking Alpha
Macrogenics (MGNX) Is Strong On High Volume Today 10:04 a.m. Nov. 24, 2014 - TheStreet.com
Will MacroGenics (MGNX) Continue to Surge Higher? - Tale of the Tape 8:39 a.m. Nov. 24, 2014 - Zacks.com
MacroGenics (MGNX) in Focus: Stock Rises 7% in Session - Tale of the Tape 8:37 a.m. Nov. 19, 2014 - Zacks.com
10-Q: MACROGENICS INC 6:13 a.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
MacroGenics' (MGNX) CEO Scott Koenig on Q3 2014 Results - Earnings Call Transcript 10:00 p.m. Nov. 11, 2014 - Seeking Alpha
What To Watch For: November 10-14 11:36 a.m. Nov. 10, 2014 - Seeking Alpha
BI begins enrollment in Phase 3 CRC trial 8:08 a.m. Oct. 21, 2014 - Seeking Alpha
MacroGenics: A Late Stage Pipeline Review 7:00 p.m. Aug. 29, 2014 - Seeking Alpha
MacroGenics' (MGNX) CEO Scott Koenig on Q2 2014 Results - Earnings Call Transcript 10:15 p.m. Aug. 5, 2014 - Seeking Alpha
10-Q: MACROGENICS INC 3:06 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
MacroGenics Announces Presentation of Pre-clinical Data on new DART(r) Candidate MGD011 at 56th Annual Meeting of the American Society of Hematology 8:30 p.m. Dec. 6, 2014 - GlobeNewswire
MacroGenics to Present at the Oppenheimer 25th Annual Healthcare Conference 7:01 a.m. Dec. 3, 2014 - GlobeNewswire
MacroGenics to Present at the Stifel 2014 Healthcare Conference 4:31 p.m. Nov. 12, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results 4:01 p.m. Nov. 11, 2014 - GlobeNewswire
MacroGenics Announces Pre-clinical Data to be Presented at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - GlobeNewswire
MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium 4:00 p.m. Oct. 30, 2014 - GlobeNewswire
MacroGenics Announces Date of Third Quarter 2014 Financial Results Conference Call 4:00 p.m. Oct. 28, 2014 - GlobeNewswire
MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additional DART Therapeutics 6:00 p.m. Sept. 29, 2014 - GlobeNewswire
MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference 3:11 p.m. Aug. 6, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results 3:07 p.m. Aug. 5, 2014 - GlobeNewswire
MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call 3:02 p.m. July 29, 2014 - GlobeNewswire
MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients 4:18 p.m. July 24, 2014 - GlobeNewswire
CMC Biologics and MacroGenics Enter into Process Validation and Clinical Manufacturing Agreement for Commercialization of Next-Generation Oncology Product Candidate 6:00 a.m. June 17, 2014 - PR Newswire - PRF
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 4:20 a.m. June 12, 2014 - PR Newswire - PRF
MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:02 a.m. May 7, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results 3:03 p.m. May 6, 2014 - GlobeNewswire
CMC Biologics and MacroGenics Enter into a Process Development and Manufacturing Agreement for Oncology Product Candidate 4:00 a.m. May 6, 2014 - PR Newswire - PRF
MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014 1:31 p.m. May 5, 2014 - GlobeNewswire
MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel 7:02 a.m. April 30, 2014 - GlobeNewswire
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More 4:00 p.m. Dec. 26, 2014 - Seeking Alpha
3D Systems Climbs Despite Setback 2:00 p.m. Dec. 26, 2014 - TheStreet.com
Macrogenics (MGNX) Highlighted As Today's Perilous Reversal Stock 3:31 p.m. Dec. 23, 2014 - TheStreet.com
MacroGenics Inks Deal with J&J for Blood Cancer Therapy - Analyst Blog 3:00 p.m. Dec. 23, 2014 - Zacks.com
MacroGenics teams up with Janssen in blood cancer 12:08 p.m. Dec. 22, 2014 - Seeking Alpha
MacroGenics Partners With J&J; Stock Jumps 11:33 a.m. Dec. 22, 2014 - Investors Business Daily
Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog 4:50 p.m. Dec. 16, 2014 - Zacks.com
Nasdaq makes annual changes to Biotechnology Index 12:36 p.m. Dec. 15, 2014 - Seeking Alpha
MacroGenics (MGNX) Stock: Moving Average Crossover Alert - Tale of the Tape 11:27 a.m. Dec. 15, 2014 - Zacks.com
B7-H3 And PD-1: Are All Checkpoint Inhibitors Created Equal? 8:43 a.m. Dec. 15, 2014 - Seeking Alpha
Macrogenics (MGNX) Is Strong On High Volume Today 10:04 a.m. Nov. 24, 2014 - TheStreet.com
Will MacroGenics (MGNX) Continue to Surge Higher? - Tale of the Tape 8:39 a.m. Nov. 24, 2014 - Zacks.com
MacroGenics (MGNX) in Focus: Stock Rises 7% in Session - Tale of the Tape 8:37 a.m. Nov. 19, 2014 - Zacks.com
10-Q: MACROGENICS INC 6:13 a.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
MacroGenics' (MGNX) CEO Scott Koenig on Q3 2014 Results - Earnings Call Transcript 10:00 p.m. Nov. 11, 2014 - Seeking Alpha
What To Watch For: November 10-14 11:36 a.m. Nov. 10, 2014 - Seeking Alpha
BI begins enrollment in Phase 3 CRC trial 8:08 a.m. Oct. 21, 2014 - Seeking Alpha
MacroGenics: A Late Stage Pipeline Review 7:00 p.m. Aug. 29, 2014 - Seeking Alpha
MacroGenics' (MGNX) CEO Scott Koenig on Q2 2014 Results - Earnings Call Transcript 10:15 p.m. Aug. 5, 2014 - Seeking Alpha
10-Q: MACROGENICS INC 3:06 p.m. Aug. 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Annual Changes to the NASDAQ Biotechnology Index 7:10 a.m. Dec. 15, 2014 - GlobeNewswire
MacroGenics Announces Presentation of Pre-clinical Data on new DART(r) Candidate MGD011 at 56th Annual Meeting of the American Society of Hematology 8:30 p.m. Dec. 6, 2014 - GlobeNewswire
MacroGenics to Present at the Oppenheimer 25th Annual Healthcare Conference 7:01 a.m. Dec. 3, 2014 - GlobeNewswire
MacroGenics to Present at the Stifel 2014 Healthcare Conference 4:31 p.m. Nov. 12, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results 4:01 p.m. Nov. 11, 2014 - GlobeNewswire
MacroGenics Announces Pre-clinical Data to be Presented at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - GlobeNewswire
MacroGenics to Present Pre-Clinical Data on MGD006 at 26th EORTC-NCI-AACR Symposium 4:00 p.m. Oct. 30, 2014 - GlobeNewswire
MacroGenics Announces Date of Third Quarter 2014 Financial Results Conference Call 4:00 p.m. Oct. 28, 2014 - GlobeNewswire
MacroGenics and Takeda Enter Second Strategic Alliance to Develop Multiple Additional DART Therapeutics 6:00 p.m. Sept. 29, 2014 - GlobeNewswire
MacroGenics to Present at the Wedbush 2014 Life Sciences Management Access Conference 3:11 p.m. Aug. 6, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and Second Quarter 2014 Financial Results 3:07 p.m. Aug. 5, 2014 - GlobeNewswire
MacroGenics Announces Date of Second Quarter 2014 Financial Results Conference Call 3:02 p.m. July 29, 2014 - GlobeNewswire
MacroGenics' DART Candidate IND for Colorectal Cancer, MGD007, Cleared to Start Enrolling Patients 4:18 p.m. July 24, 2014 - GlobeNewswire
CMC Biologics and MacroGenics Enter into Process Validation and Clinical Manufacturing Agreement for Commercialization of Next-Generation Oncology Product Candidate 6:00 a.m. June 17, 2014 - PR Newswire - PRF
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 4:20 a.m. June 12, 2014 - PR Newswire - PRF
MacroGenics to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:02 a.m. May 7, 2014 - GlobeNewswire
MacroGenics Provides Update on Corporate Progress and First Quarter 2014 Financial Results 3:03 p.m. May 6, 2014 - GlobeNewswire
CMC Biologics and MacroGenics Enter into a Process Development and Manufacturing Agreement for Oncology Product Candidate 4:00 a.m. May 6, 2014 - PR Newswire - PRF
MacroGenics Presents Pre-Clinical Data on Inhibition of Autoimmune Diseases With DART Candidate MGD010 at IMMUNOLOGY 2014 1:31 p.m. May 5, 2014 - GlobeNewswire
MacroGenics Appoints Atul Saran as Senior Vice President and General Counsel 7:02 a.m. April 30, 2014 - GlobeNewswire
(0)
(0)